Michael S. Schechter

Michael S. Schechter

Auto-generated profile, based on publicly available information

Michael S. Schechter

Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, VA, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2023 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
SRS.M. Rowe
S.M. Rowe
JZJ.B. Zuckerman
J.B. Zuckerman
DDD. Dorgan
D. Dorgan
JLJ. Lascano
J. Lascano
KMK. McCoy
K. McCoy
ABA.J. Barbier
A.J. Barbier

5 April 2022 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
SSSylvia Szentpetery
Sylvia Szentpetery
GFGabriela S. Fernandez
Gabriela S. Fernandez
MSMichael S. Schechter
Michael S. Schechter
RJRaksha Jain
Raksha Jain
PFPatrick A. Flume
Patrick A. Flume
AFAliza K Fink
Aliza K Fink

1 April 2015 in Pediatrics
Verified
Journal Article
Open access
PDF file
MSMichael S. Schechter
Michael S. Schechter
TLTiebin Liu
Tiebin Liu
MSMinn Soe
Minn Soe
MSMark Swanson
Mark Swanson
EWElisabeth Ward
Elisabeth Ward
JTJudy Thibadeau
Judy Thibadeau
BACKGROUND: A National Spina Bifida Patient Registry (NSBPR) was begun in 2009 to help understand the natural history of spina bifida (SB) and the effects of treatments provided by SB clinics. We used the NSBPR to explore the relationship of sociodemographic characteristics with SB outcomes.METHODS: Using NSBPR data collected in 2009 to 2012, we examined the unadjusted association between demographic characteristics and 4 SB outcomes: bowel continence, bladder continence, mobility, and presence of pressure sores. We then developed multivariable logistic models to explore these relationships while controlling for SB clinic, SB type, and level of lesion.RESULTS: Data were available on 2054 patients <22 years of age from 10 SB clinics. In the multivariable models, older age groups were more likely to have continence and pressure sores and less likely to be community ambulatory. Males and patients without private insurance were less likely to be continent and community ambulatory. Non-Hispanic blacks were less likely to be continent. Level of lesion was associated with all outcomes; SB type was associated with all but pressure sores; and all outcomes except community ambulation showed significant variation across clinic sites.CONCLUSIONS: Sociodemographic attributes are associated with SB outcomes. In particular, males, non-Hispanic blacks, and patients without private insurance have less favorable outcomes, and age has an impact as well. These characteristics need to be considered by clinicians who care for this patient population and factored into case-mix adjustment when evaluating variation in clinical and functional outcomes among different SB clinics.

1 June 2013 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
MSMichael S. Schechter
Michael S. Schechter
AQAlexandra L. Quittner
Alexandra L. Quittner
MKMichael W. Konstan
Michael W. Konstan
SMStefanie J. Millar
Stefanie J. Millar
DPDavid J. Pasta
David J. Pasta
AMAnn McMullen
Ann McMullen
Studies of pregnancy in cystic fibrosis (CF) have shown no short-term harmful effects, but there are no long-term studies on the impact of motherhood. This study sought to evaluate longer-term physiologic and functional outcomes in women with CF reporting a pregnancy, with the intent of assessing how the demands of parenting impacted on disease course. Using 1994 to 2005 Epidemiologic Study of Cystic Fibrosis data, we developed a propensity score to match women reporting a pregnancy at a 1:10 ratio with never-pregnant control subjects and compared clinical outcomes, health-related quality of life, and health care use. One hundred nineteen pregnant women presumed to have become mothers were matched with 1,190 control subjects, a median of 6.0 years (range 1.8-11.1 yr) from the pregnancy. No differences were found in annualized change from baseline FEV1 and body mass index, in respiratory signs and symptoms, or in prescribed chronic therapies. Women who had been pregnant were treated for more pulmonary exacerbations and had more illness-related clinic visits but showed no increase in prescribed chronic therapies. They also reported lower health-related quality-of-life scores for Respiratory Symptoms, Physical Functioning, Vitality, and Health Perceptions. Pregnancy and motherhood do not appear to accelerate disease progression but lead to more illness-related visits, pulmonary exacerbations, and a decrease in some domains of quality of life. These differences presumably reflect the impact of the physical and emotional challenges of early motherhood on disease self-management.

1 January 2021 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
MSMichael S. Schechter
Michael S. Schechter
JOJoshua S. Ostrenga
Joshua S. Ostrenga
AFAliza K. Fink
Aliza K. Fink
DBDavid H. Barker
David H. Barker
GSGregory S. Sawicki
Gregory S. Sawicki
AQAlexandra L. Quittner
Alexandra L. Quittner

18 December 2021 in Journal of Cystic Fibrosis
Verified
Journal Article
Open access
DADana Albon
Dana Albon
ACAricca D Van Citters
Aricca D Van Citters
TOThida Ong
Thida Ong
ODOlivia Dieni
Olivia Dieni
CDChristopher Dowd
Christopher Dowd
MSMichael S. Schechter
Michael S. Schechter
Due to the COVID-19 pandemic, there was an uptake of telehealth in cystic fibrosis care. Previous studies show disparities in telehealth use based on socioeconomic status (SES). We aimed to: (1) understand telehealth use and perceptions and (2) identify the facilitators and barriers to telehealth use among people with CF and their families (PwCF) from diverse racial/ethnic and socioeconomic backgrounds. We conducted an analysis of the 2020 Cystic Fibrosis State of Care surveys completed by PwCF (PFSoC), CF Care Programs (SoC1) and the CF Foundation Patient Registry (CFFPR). A total of 424 PwCF and 286 programs responded to the PFSoC and SoC1. Among PwCF, 90% self-identified as White, 6% as Hispanic/Latino, and 2% as Black. Racial/ethnic minorities were less likely to have had a telehealth visit (p=.015). This difference was pronounced among the Hispanic/Latino population (p<.01). Telehealth use did not differ by health insurance and was similarly offered independent of financial status. Compared to PwCF who denied financial constraints, those who reported financial difficulties found telehealth more difficult to use (p=.018) and were less likely to think that their concerns (p=.010) or issues that mattered most to them (p=.020) were addressed during telehealth. Programs perceived lack of technology, language barriers, and home conditions as barriers to telehealth in vulnerable populations. PFSoC and SoC1 identified differences in telehealth use and care perceptions by ethnicity, race, and socioeconomic characteristics. Further studies are needed to understand how telehealth can change access to CF care in diverse subpopulations.